August 26, 2019 — Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-based solutions for ultrasound analysis, to provide its cardiac solutions on Terason's point-of-care ultrasound devices.
The partnership fills a market need, according to the companies, for more accurate and objective image analysis for clinicians in hospitals and outpatient settings, that commonly analyze ultrasound images visually.
DiA's flagship, U.S. Food and Drug Administration (FDA)-cleared and CE marked cardiac solution, LVivo Toolbox, leverages its pattern recognition, machine learning and deep learning-based technology to identify cardiac functions and abnormalities. LVivo's AI-based algorithms generate fast, quantitative and objective results that support clinicians' decision-making process and reduce the subjectivity associated with cardiac ultrasound analysis.
Terason systems are routinely used in the fields of cardiology, vascular surgery, interventional radiology, endocrinology, nephrology, musculoskeletal (MSK) and breast surgery. In addition, Terason said it is the first company to turn a laptop into an ultrasound machine.
For more information: www.dia-analysis.com, www.terason.com
September 10, 2026 
